Strata Critical Medical, Inc. (SRTA)
NASDAQ: SRTA · Real-Time Price · USD
4.560
-0.095 (-2.04%)
Mar 13, 2026, 4:00 PM EDT - Market closed

Strata Critical Medical Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
41.35-27.31-56.08-27.26-36.92
Depreciation & Amortization
8.195.967.115.731.17
Stock-Based Compensation
17.8319.8912.58.2811.28
Other Adjustments
-107.21.9410.85-23.865.4
Change in Receivables
-12.03-1-10.25-5.35-1.74
Changes in Accounts Payable
2.38-8.349.059.92.52
Changes in Unearned Revenue
1.68-0.120.120.741.56
Changes in Other Operating Activities
-1.116.45-5.65-5.31-4.9
Operating Cash Flow
-48.91-2.52-32.35-37.13-21.63
Capital Expenditures
-9.6-30.86--0.73-0.49
Sale of Property, Plant & Equipment
--0.14--
Purchases of Intangible Assets
-1.42-2.12-0.04--12.36
Purchases of Investments
-146.26-143.26-265.97-228.02-308.77
Proceeds from Sale of Investments
296.36177.45285.07356.3828.51
Payments for Business Acquisitions
-66.54-2.23--48.1-23.07
Proceeds from Business Divestments
-2.81----
Other Investing Activities
---2.11-0.19-
Investing Cash Flow
69.75-1.0217.0979.34-316.17
Long-Term Debt Repaid
-----1.17
Net Long-Term Debt Issued (Repaid)
-----1.17
Issuance of Common Stock
0.190.170.070.09335.04
Repurchase of Common Stock
-9.11-5.93-0.15-1.17-3.17
Net Common Stock Issued (Repurchased)
-8.91-5.76-0.08-1.08331.87
Financing Cash Flow
-8.91-5.76-0.08-1.08330.7
Effect of Exchange Rate Changes on Cash and Cash Equivalents
-0.34-0.08-0.070.07-0.01
Net Cash Flow
11.59-9.37-15.441.2-7.11
Free Cash Flow
-58.51-33.38-32.35-37.86-22.12
FCF Margin
-29.68%-22.74%-14.37%-25.91%-32.93%
Free Cash Flow Per Share
-0.71-0.43-0.44-0.53-
Levered Free Cash Flow
42.89-54.22-45.45-16.94-38.22
Unlevered Free Cash Flow
-20.81-49.44-55.75-41.73-29.42
Updated Mar 3, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q